Stock Detail
PEREGRINE PHARMACEUTICALS INC
Biotechnology
PPHM @ Yahoo Finance | PPHM Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $0.94 | $1.01 | $-0.05 | -5.05% | 0.00 | $0.99 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $0.98 | $0.93 | 621,005 | 74.76M | 524,228.5 | -1.77 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 1.04 | 0.99 | 0.96 | 0.91 | 0.88 |
Stock Profile
Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for the treatment of cancer, viruses, and other diseases using targeted antibodies. The company's products portfolio includes Cotara for brain cancer, which is in Phase II/III registration trial, and Tarvacin, an anti-phospholipid therapy agent for the treatment of solid tumors and chronic hepatitis C virus infection. Its vascular research programs fall under various technology platforms, including tumor necrosis therapy, antiphospholipid therapy, vascular targeting agents, antiangiogenesis, and vasopermeation enhancement agent technology. In addition, the company, through its wholly owned subsidiary, Avid Bioservices, Inc., provides a range of contract manufacturing services, including contract manufacturing of antibodies and proteins, cell culture development, process development, and testing of biologics for biopharmaceutical and biotechnology companies. The company was founded in 1981 as Techniclone International Corporation. It changed its name to Techniclone Corporation in 1997 and to Peregrine Pharmaceuticals, Inc. in 2000. Peregrine Pharmaceuticals is based in Tustin, California.